Loading...
BVMFDASA3
Market cap393mUSD
Dec 23, Last price  
1.92BRL
1D
5.98%
1Q
-29.60%
Jan 2017
-88.99%
Name

Diagnosticos da America SA

Chart & Performance

D1W1MN
BVMF:DASA3 chart
P/E
—
P/S
0.17
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
17.63%
Rev. gr., 5y
29.37%
Revenues
14.25b
+8.56%
528,280,000670,450,000858,820,0001,137,525,0001,388,313,0001,501,967,0002,179,874,0002,264,142,0002,487,487,0002,697,573,0002,794,399,0003,040,775,0003,399,308,0003,933,451,0004,364,585,0007,039,331,00010,418,674,00013,128,893,00014,252,235,000
Net income
-1.17b
L+200.70%
10,157,00016,511,00056,621,000-12,980,00084,997,00097,966,000145,255,00085,192,000131,301,00082,289,00023,813,00094,738,000131,443,000184,378,000124,777,000-147,739,000-216,937,000-387,766,000-1,166,016,000
CFO
-964m
L
107,648,000132,873,000383,383,000338,606,000106,244,000195,293,000-25,643,000315,495,000254,980,000459,222,000494,329,000841,937,000653,235,000530,331,000699,366,000766,504,0001,298,179,0001,339,682,000-963,624,000
Dividend
Dec 27, 20220.096871 BRL/sh
Earnings
Mar 25, 2025

Profile

Diagnósticos da América S.A. provides diagnostic test services in Latin America. It offers approximately 3,000 types of examinations of clinical analyses and diagnostic imaging services. The company also provides support services to approximately 5,000 laboratories under the Alvaro brand, as well as operates for the public sector under the CientíficaLab brand. The company was formerly known as Laboratório Clínico Delboni Auriemo S.A. and changed its name to Diagnósticos da América S.A. in August 17, 2000. The company was founded in 1966 and is based in Barueri, Brazil.
URL
https://www.dasa3.com.br/
IPO date
Nov 19, 2004
Employees
Domiciled in
BR
Incorporated in
BR

Valuation

Title
BRL in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
14,252,235
8.56%
13,128,893
26.01%
10,418,674
48.01%
Cost of revenue
13,340,533
10,556,864
8,311,407
Unusual Expense (Income)
NOPBT
911,702
2,572,029
2,107,267
NOPBT Margin
6.40%
19.59%
20.23%
Operating Taxes
133,816
(191,029)
(157,290)
Tax Rate
14.68%
NOPAT
777,886
2,763,058
2,264,557
Net income
(1,166,016)
200.70%
(387,766)
78.75%
(216,937)
46.84%
Dividends
(159,241)
(220,250)
Dividend yield
2.08%
1.16%
Proceeds from repurchase of equity
1,565,765
(37,917)
5,470,682
BB yield
-21.79%
0.49%
-28.93%
Debt
Debt current
1,897,394
1,169,608
2,107,599
Long-term debt
14,040,425
14,241,726
9,098,356
Deferred revenue
Other long-term liabilities
1,827,574
1,788,959
1,772,400
Net debt
14,121,022
14,126,321
7,591,897
Cash flow
Cash from operating activities
(963,624)
1,339,682
1,298,179
CAPEX
(811,249)
(1,136,157)
(905,805)
Cash from investing activities
978,958
(1,599,800)
(4,951,718)
Cash from financing activities
284,868
1,770,765
4,042,958
FCF
246,758
592,456
544,387
Balance
Cash
1,664,755
1,285,013
3,614,058
Long term investments
152,042
Excess cash
1,104,185
628,568
3,093,124
Stockholders' equity
16,269,817
7,128,601
7,549,803
Invested Capital
21,351,836
21,219,316
15,314,712
ROIC
3.65%
15.13%
18.24%
ROCE
4.06%
11.77%
11.45%
EV
Common stock shares outstanding
747,048
558,184
560,419
Price
9.62
-29.93%
13.73
-59.31%
33.74
-53.46%
Market cap
7,186,602
-6.23%
7,663,866
-59.47%
18,908,538
-45.75%
EV
21,311,016
21,800,964
26,506,665
EBITDA
2,208,006
3,683,552
3,037,028
EV/EBITDA
9.65
5.92
8.73
Interest
1,907,732
1,601,770
523,149
Interest/NOPBT
209.25%
62.28%
24.83%